Evidence that genetic instability occurs at an early stage of colorectal tumorigenesis - PubMed (original) (raw)
. 2001 Feb 1;61(3):818-22.
Affiliations
- PMID: 11221861
Evidence that genetic instability occurs at an early stage of colorectal tumorigenesis
I M Shih et al. Cancer Res. 2001.
Abstract
Chromosomal instability is believed to be a common feature of most human tumors, but the stage at which such instability originates has not been defined. At the molecular level, chromosomal instability is characterized by allelic imbalance (AI), representing losses or gains of defined chromosomal regions. We have assessed AI in early colorectal tumors using newly developed methods for assessing AI in complex cell populations. A total of 32 adenomas of average size (2 mm; range, 1-3 mm) were studied. AI of chromosome 5q markers occurred in 55% of tumors analyzed, consistent with a gatekeeping role of the adenomatous polyposis coli tumor suppressor gene located at chromosomal position 5q21. AI was also detected in each of the other four chromosomes tested. The fractions of adenomas with AI of chromosomes 1p, 8p, 15q, and 18q were 10,19, 28, and 28%, respectively. Over 90% of the tumors exhibited AI of at least one chromosome, and 67% had allelic imbalance of a chromosome other than 5q. These findings demonstrate that AI is a common event, even in very small tumors, and suggest that chromosomal instability occurs very early during colorectal neoplasia.
Similar articles
- Analysis of genetic alterations, classified according to their DNA ploidy pattern, in the progression of colorectal adenomas and early colorectal carcinomas.
Sugai T, Takahashi H, Habano W, Nakamura S, Sato K, Orii S, Suzuki K. Sugai T, et al. J Pathol. 2003 Jun;200(2):168-76. doi: 10.1002/path.1340. J Pathol. 2003. PMID: 12754737 - Analysis of copy number changes suggests chromosomal instability in a minority of large colorectal adenomas.
Jones AM, Thirlwell C, Howarth KM, Graham T, Chambers W, Segditsas S, Page KM, Phillips RK, Thomas HJ, Sieber OM, Sawyer EJ, Tomlinson IP. Jones AM, et al. J Pathol. 2007 Nov;213(3):249-56. doi: 10.1002/path.2234. J Pathol. 2007. PMID: 17893889 - Recurrent deletions involving chromosomes 1, 5, 17, and 18 in colorectal carcinoma: possible role in biological and clinical behavior of tumors.
Gerdes H, Chen Q, Elahi AH, Sircar A, Goldberg E, Winawer D, Urmacher C, Winawer SJ, Jhanwar SC. Gerdes H, et al. Anticancer Res. 1995 Jan-Feb;15(1):13-24. Anticancer Res. 1995. PMID: 7733622 - A systematic review and meta-analysis of the relationship between chromosome 18q genotype, DCC status and colorectal cancer prognosis.
Popat S, Houlston RS. Popat S, et al. Eur J Cancer. 2005 Sep;41(14):2060-70. doi: 10.1016/j.ejca.2005.04.039. Eur J Cancer. 2005. PMID: 16125380 Review. - The significance of unstable chromosomes in colorectal cancer.
Rajagopalan H, Nowak MA, Vogelstein B, Lengauer C. Rajagopalan H, et al. Nat Rev Cancer. 2003 Sep;3(9):695-701. doi: 10.1038/nrc1165. Nat Rev Cancer. 2003. PMID: 12951588 Review.
Cited by
- Cellular and molecular events in colorectal cancer: biological mechanisms, cell death pathways, drug resistance and signalling network interactions.
Yan L, Shi J, Zhu J. Yan L, et al. Discov Oncol. 2024 Jul 20;15(1):294. doi: 10.1007/s12672-024-01163-1. Discov Oncol. 2024. PMID: 39031216 Free PMC article. Review. - Organoids and metastatic orthotopic mouse model for mismatch repair-deficient colorectal cancer.
Song Y, Kerr TD, Sanders C, Dai L, Baxter SS, Somerville B, Baugher RN, Mellott SD, Young TB, Lawhorn HE, Plona TM, Xu B, Wei L, Hu Q, Liu S, Hutson A, Karim B, Burkett S, Difilippantonio S, Pinto L, Gebert J, Kloor M, Lipkin SM, Sei S, Shoemaker RH. Song Y, et al. Front Oncol. 2023 Sep 8;13:1223915. doi: 10.3389/fonc.2023.1223915. eCollection 2023. Front Oncol. 2023. PMID: 37746286 Free PMC article. - High expression of KNL1 in prostate adenocarcinoma is associated with poor prognosis and immune infiltration.
Zhang Y, Ji Q, Wang J, Dong Y, Pang M, Fu S, Wei Y, Zhu Q. Zhang Y, et al. Front Genet. 2023 Jan 6;13:1100787. doi: 10.3389/fgene.2022.1100787. eCollection 2022. Front Genet. 2023. PMID: 36685823 Free PMC article. - The Renaissance of CDK Inhibitors in Breast Cancer Therapy: An Update on Clinical Trials and Therapy Resistance.
Abdelmalak M, Singh R, Anwer M, Ivanchenko P, Randhawa A, Ahmed M, Ashton AW, Du Y, Jiao X, Pestell R. Abdelmalak M, et al. Cancers (Basel). 2022 Nov 1;14(21):5388. doi: 10.3390/cancers14215388. Cancers (Basel). 2022. PMID: 36358806 Free PMC article. Review. - Receptor Guanylyl Cyclase C and Cyclic GMP in Health and Disease: Perspectives and Therapeutic Opportunities.
Prasad H, Mathew JKK, Visweswariah SS. Prasad H, et al. Front Endocrinol (Lausanne). 2022 Jun 29;13:911459. doi: 10.3389/fendo.2022.911459. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 35846281 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical